Unknown

Dataset Information

0

Type I-F CRISPR-Cas provides protection from DNA, but not RNA phages.

ABSTRACT:

SUBMITTER: Buyukyoruk M 

PROVIDER: S-EPMC6868142 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Type I-F CRISPR-Cas provides protection from DNA, but not RNA phages.

Buyukyoruk Murat M   Wiedenheft Blake B  

Cell discovery 20191022

Similar Datasets

Unknown Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity.
| S-EPMC6892833 | biostudies-literature
Unknown Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity.
| S-EPMC4594840 | biostudies-literature
Unknown Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity.
| S-EPMC6086933 | biostudies-literature
Unknown Targeting of temperate phages drives loss of type I CRISPR-Cas systems.
| S-EPMC7007301 | biostudies-literature
Unknown RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex.
| S-EPMC4762430 | biostudies-literature
Unknown Programmable type III-A CRISPR-Cas DNA targeting modules.
| S-EPMC5404769 | biostudies-literature
Unknown DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes.
| S-EPMC5965380 | biostudies-literature
Unknown RNA activation-independent DNA targeting of the Type III CRISPR-Cas system by a Csm complex.
| S-EPMC5412804 | biostudies-literature
Unknown Lactococcus lactis type III-A CRISPR-Cas system cleaves bacteriophage RNA.
| S-EPMC6546414 | biostudies-literature
Unknown RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
| S-EPMC5999320 | biostudies-literature